Pan-Bcl-2 Inhibitor AT-101 Enhances Tumor Cell Killing by EGFR Targeted T Cells

Pancreatic cancer is a deadly disease and has the worst prognosis among almost all cancers and is in dire need of new and improved therapeutic strategies. Conditioning of tumor cells with chemotherapeutic drug has been shown to enhance the anti-tumor effects of cancer vaccines and adoptive cell ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakur, Archana, Lum, Lawrence G., Schalk, Dana, Azmi, Asfar, Banerjee, Sanjeev, Sarkar, Fazlul H., Mohommad, Ramzi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501501/
https://www.ncbi.nlm.nih.gov/pubmed/23185240
http://dx.doi.org/10.1371/journal.pone.0047520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501501/
https://www.ncbi.nlm.nih.gov/pubmed/23185240
http://dx.doi.org/10.1371/journal.pone.0047520

Ejemplares similares